Results 281 to 290 of about 36,694,375 (388)

A Psychometric Perspective on the Associations between Response Accuracy and Response Time Residuals. [PDF]

J Intell
Lyu W, Bolt D.
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Correction: Revealing the photocatalytic dissociation of water molecules on rutile TiO₂ surface <i>via</i> hybrid functional based linear response time-dependent density functional theory. [PDF]

Chem Sci
Wang L, Liu X, Li Q, Yang J, Hu W.
europepmc   +1 more source

Changing Times, Evolving Responses

Indian Journal of Ophthalmology, 2005
openaire   +3 more sources

Quantification of Hepatitis Delta Virus RNA in Serum by Consensus Real-Time PCR Indicates Different Patterns of Virological Response to Interferon Therapy in Chronically Infected Patients

, 2005
Frédéric Le Gal, Emmanuel Gordien, Dissou Affolabi, Thomas Hanslik, Chakib Alloui, Paul Dény, Elyanne Gault   +6 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Measuring Cognitive Function and Cognitive Decline With Response Time Data in the National Social Life, Health, and Aging Project. [PDF]

J Gerontol B Psychol Sci Soc Sci
Sanders S, Schofield LS, Schumm LP, Waite L.   +3 more
europepmc   +1 more source

Support for Holistic Response-Time Analysis in an Industrial Tool Suite: Implementation Issues, Experiences and a Case Study

, 2012
Saad Mubeen, Jukka Mäki-Turja, Mikael Sjödin   +2 more
openalex   +2 more sources